TENAX THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
TENAX THERAPEUTICS, INC. (TENX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$546.56 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2024-11-13
- TENAX THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-09-30 was $1.09M.
- TENAX THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-06-30 was -$164.56K.
- TENAX THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-03-31 was -$1.48M.
- TENAX THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-12-31 was $2.66M, a 401.71% increase year-over-year.
- TENAX THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $1.89M.
- TENAX THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$344.95K.
- TENAX THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was -$544.59K.
- TENAX THERAPEUTICS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was -$535.55K, a 160.65% decline from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 8 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 530 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 533 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 536 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 539 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 542 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 545 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 554 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $928.64K derived: sum of 2 quarters · filed 2024-11-13 | -$546.56K 10-Q · filed 2024-11-13 | $2.11M derived: sum of 4 quarters · filed 2024-11-13 | |||||||||
| 2024-06-30 | -$164.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$1.64M 10-Q · filed 2024-08-13 | $1.02M derived: sum of 3 quarters · filed 2024-08-13 | $956.70K derived: sum of 4 quarters · filed 2024-11-13 | |||||||||
| 2024-03-31 | -$1.48M 10-Q · filed 2024-05-14 | $1.18M derived: sum of 2 quarters · filed 2024-05-14 | $1.12M derived: sum of 3 quarters · filed 2024-11-13 | $1.04M derived: sum of 4 quarters · filed 2024-11-13 | |||||||||
| 2023-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.60M derived: sum of 2 quarters · filed 2024-11-13 | $2.52M derived: sum of 3 quarters · filed 2024-11-13 | $1.89M 10-K · filed 2024-03-28 | |||||||||
| 2023-09-30 | -$58.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$137.16K derived: sum of 2 quarters · filed 2024-11-13 | -$765.73K 10-Q · filed 2024-11-13 | -$236.53K derived: sum of 4 quarters · filed 2024-11-13 | |||||||||
| 2023-06-30 | -$78.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$707.14K 10-Q · filed 2024-08-13 | -$177.94K derived: sum of 3 quarters · filed 2024-08-13 | -$842.04K derived: sum of 4 quarters · filed 2024-08-13 | |||||||||
| 2023-03-31 | -$628.57K 10-Q · filed 2024-05-14 | -$99.36K derived: sum of 2 quarters · filed 2024-05-14 | -$763.46K derived: sum of 3 quarters · filed 2024-05-14 | -$1.16M derived: sum of 4 quarters · filed 2024-05-14 | |||||||||
| 2022-12-31 | $529.21K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$134.90K derived: sum of 2 quarters · filed 2024-03-28 | -$528.61K derived: sum of 3 quarters · filed 2024-03-28 | -$344.95K 10-K · filed 2024-03-28 | |||||||||
| 2022-09-30 | -$664.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$1.06M derived: sum of 2 quarters · filed 2023-11-13 | -$874.16K 10-Q · filed 2023-11-13 | -$774.43K derived: sum of 4 quarters · filed 2023-11-13 | |||||||||
| 2022-06-30 | -$393.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$210.06K 10-Q · filed 2023-08-14 | -$110.33K derived: sum of 3 quarters · filed 2023-08-14 | $168.65K derived: sum of 4 quarters · filed 2023-08-14 | |||||||||
| 2022-03-31 | $183.65K 10-Q · filed 2023-05-15 | $283.38K derived: sum of 2 quarters · filed 2023-05-15 | $562.36K derived: sum of 3 quarters · filed 2023-05-15 | $417.93K derived: sum of 4 quarters · filed 2023-05-15 | |||||||||
| 2021-12-31 | $99.72K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $378.71K derived: sum of 2 quarters · filed 2023-03-31 | $234.27K derived: sum of 3 quarters · filed 2023-03-31 | -$544.59K 10-K · filed 2023-03-31 | |||||||||
| 2021-09-30 | $278.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $134.55K derived: sum of 2 quarters · filed 2022-11-10 | -$644.31K 10-Q · filed 2022-11-10 | $5.28K derived: sum of 4 quarters · filed 2022-11-10 | |||||||||
| 2021-06-30 | -$144.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$923.29K 10-Q · filed 2022-08-11 | -$273.71K derived: sum of 3 quarters · filed 2022-08-11 | -$1.01M derived: sum of 4 quarters · filed 2022-08-11 | |||||||||
| 2021-03-31 | -$778.86K 10-Q · filed 2022-05-16 | -$129.28K derived: sum of 2 quarters · filed 2022-05-16 | -$861.01K derived: sum of 3 quarters · filed 2022-05-16 | -$1.29M derived: sum of 4 quarters · filed 2022-05-16 | |||||||||
| 2020-12-31 | $649.59K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$82.14K derived: sum of 2 quarters · filed 2022-03-29 | -$508.61K derived: sum of 3 quarters · filed 2022-03-29 | -$535.55K 10-K · filed 2022-03-29 | |||||||||
| 2020-09-30 | -$731.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$1.16M derived: sum of 2 quarters · filed 2021-11-15 | -$1.19M 10-Q · filed 2021-11-15 | $196.05K derived: sum of 4 quarters · filed 2021-11-15 | |||||||||
| 2020-06-30 | -$426.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$453.41K 10-Q · filed 2021-08-16 | $927.78K derived: sum of 3 quarters · filed 2021-08-16 | $1.15M derived: sum of 4 quarters · filed 2021-08-16 | |||||||||
| 2020-03-31 | -$26.95K 10-Q · filed 2021-05-17 | $1.35M derived: sum of 2 quarters · filed 2021-05-17 | $1.57M derived: sum of 3 quarters · filed 2021-05-17 | $1.53M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||
| 2019-12-31 | $1.38M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | $1.60M derived: sum of 2 quarters · filed 2021-04-16 | $1.55M derived: sum of 3 quarters · filed 2021-04-16 | $883.04K 10-K/A · filed 2021-04-16 | |||||||||
| 2019-09-30 | $219.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $170.77K derived: sum of 2 quarters · filed 2020-11-16 | -$498.14K 10-Q · filed 2020-11-16 | $570.74K derived: sum of 4 quarters · filed 2020-11-16 | |||||||||
| 2019-06-30 | -$48.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$717.32K 10-Q · filed 2020-08-14 | $351.56K derived: sum of 3 quarters · filed 2020-08-14 | $343.96K derived: sum of 4 quarters · filed 2020-08-14 | |||||||||
| 2019-03-31 | -$668.91K 10-Q · filed 2020-05-15 | $399.97K derived: sum of 2 quarters · filed 2020-05-15 | $392.37K derived: sum of 3 quarters · filed 2020-05-15 | $745.27K derived: sum of 4 quarters · filed 2020-05-15 | |||||||||
| 2018-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.06M derived: sum of 2 quarters · filed 2020-03-30 | $1.41M derived: sum of 3 quarters · filed 2020-03-30 | $729.36K 10-K · filed 2020-03-30 | |||||||||
| 2018-09-30 | -$7.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $345.30K derived: sum of 2 quarters · filed 2019-11-14 | -$339.53K 10-Q · filed 2019-11-14 | -$166.84K derived: sum of 4 quarters · filed 2019-11-14 | |||||||||
| 2018-06-30 | $352.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$331.93K 10-Q · filed 2019-08-14 | -$159.24K derived: sum of 3 quarters · filed 2019-08-14 | -$1.47M derived: sum of 4 quarters · filed 2019-08-14 | |||||||||
| 2018-03-31 | -$684.83K 10-Q · filed 2019-05-15 | -$512.14K derived: sum of 2 quarters · filed 2019-05-15 | -$1.82M derived: sum of 3 quarters · filed 2019-05-15 | -$4.70M derived: sum of 4 quarters · filed 2019-05-15 | |||||||||
| 2017-12-31 | $172.69K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$1.14M derived: sum of 2 quarters · filed 2019-04-01 | -$4.01M derived: sum of 3 quarters · filed 2019-04-01 | -$5.00M 10-K · filed 2019-04-01 | |||||||||
| 2017-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$4.18M derived: sum of 2 quarters · filed 2018-11-14 | -$5.17M 10-Q · filed 2018-11-14 | -$3.94M derived: sum of 4 quarters · filed 2018-11-14 | |||||||||
| 2017-06-30 | -$2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$3.86M 10-Q · filed 2018-08-14 | -$2.64M derived: sum of 3 quarters · filed 2018-08-14 | -$2.80M derived: sum of 4 quarters · filed 2018-08-14 | |||||||||
| 2017-03-31 | -$987.13K 10-Q · filed 2018-05-15 | $239.26K derived: sum of 2 quarters · filed 2018-05-15 | $78.75K derived: sum of 3 quarters · filed 2018-05-15 | -$965.46K derived: sum of 4 quarters · filed 2018-05-15 | |||||||||
| 2016-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.07M derived: sum of 2 quarters · filed 2018-04-02 | $21.67K derived: sum of 3 quarters · filed 2018-04-02 | $1.90M 10-K · filed 2018-04-02 | |||||||||
| 2016-09-30 | -$160.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.20M derived: sum of 2 quarters · filed 2017-11-09 | $669.46K 10-Q · filed 2017-11-09 | ||||||||||
| 2016-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $829.98K 10-Q · filed 2017-08-09 | |||||||||||
| 2016-03-31 | $1.87M 10-Q · filed 2017-05-10 | ||||||||||||
| 2015-12-31 | $232.68K 10-K · filed 2017-03-16 | ||||||||||||
| 2015-10-31 | $459.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | -$784.71K 10-Q · filed 2015-12-10 | |||||||||||
| 2015-09-30 | -$612.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$63.05K 10-Q · filed 2016-11-09 | |||||||||||
| 2015-07-31 | -$1.24M 10-Q · filed 2015-09-09 | ||||||||||||
| 2015-06-30 | $306.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $549.93K 10-Q · filed 2016-08-09 | |||||||||||
| 2015-04-30 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $2.72M 10-K · filed 2017-03-16 | |||||||||||
| 2015-03-31 | $243.29K 10-Q · filed 2016-05-10 | ||||||||||||
| 2015-01-31 | -$820.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $937.51K derived: sum of 2 quarters · filed 2015-12-10 | $1.02M 10-Q · filed 2015-03-17 | $57.19K derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-10-31 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | $1.84M 10-Q · filed 2015-12-10 | $877.52K derived: sum of 3 quarters · filed 2017-03-16 | $431.80K derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-07-31 | $78.59K 10-Q · filed 2015-09-09 | -$880.32K derived: sum of 2 quarters · filed 2017-03-16 | -$1.33M derived: sum of 3 quarters · filed 2017-03-16 | -$1.30M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-04-30 | -$958.91K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$1.40M derived: sum of 2 quarters · filed 2017-03-16 | -$1.38M derived: sum of 3 quarters · filed 2017-03-16 | -$2.09M 10-K · filed 2017-03-16 | |||||||||
| 2014-01-31 | -$445.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -$420.07K derived: sum of 2 quarters · filed 2015-03-17 | -$1.13M 10-Q · filed 2015-03-17 | -$1.19M derived: sum of 4 quarters · filed 2016-03-14 | $882.08K 10-Q · filed 2014-03-17 | ||||||||
| 2013-10-31 | $25.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | -$684.48K 10-Q · filed 2014-12-15 | -$741.58K derived: sum of 3 quarters · filed 2016-03-14 | $227.52K derived: sum of 4 quarters · filed 2016-03-14 | $1.33M 10-Q · filed 2013-12-17 | ||||||||
| 2013-07-31 | -$710.13K 10-Q · filed 2014-09-15 | -$767.24K derived: sum of 2 quarters · filed 2016-03-14 | $201.86K derived: sum of 3 quarters · filed 2016-03-14 | -$760.75K derived: sum of 4 quarters · filed 2016-03-14 | $1.30M 10-Q · filed 2013-09-17 | ||||||||
| 2013-04-30 | -$57.10K derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | $912.00K derived: sum of 2 quarters · filed 2016-03-14 | -$50.62K derived: sum of 3 quarters · filed 2016-03-14 | $70.15K 10-KT · filed 2016-03-14 | $2.01M 10-K · filed 2013-06-26 | ||||||||
| 2013-01-31 | $969.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $6.48K derived: sum of 2 quarters · filed 2014-03-17 | $127.25K 10-Q · filed 2014-03-17 | $157.84K derived: sum of 4 quarters · filed 2014-03-17 | $2.07M 10-Q · filed 2013-03-18 | ||||||||
| 2012-10-31 | -$962.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-17 | -$841.85K 10-Q · filed 2013-12-17 | -$811.26K derived: sum of 3 quarters · filed 2013-12-17 | -$1.13M derived: sum of 4 quarters · filed 2013-12-17 | $1.10M 10-Q · filed 2012-12-14 | ||||||||
| 2012-07-31 | $120.77K 10-Q · filed 2013-09-17 | $151.36K derived: sum of 2 quarters · filed 2013-09-17 | -$170.86K derived: sum of 3 quarters · filed 2013-09-17 | -$332.69K derived: sum of 4 quarters · filed 2013-09-17 | $2.06M 10-Q · filed 2012-09-19 | ||||||||
| 2012-04-30 | $30.59K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | -$291.63K derived: sum of 2 quarters · filed 2013-06-26 | -$453.46K derived: sum of 3 quarters · filed 2013-06-26 | -$404.37K 10-K · filed 2013-06-26 | $1.94M 10-K · filed 2012-07-25 | ||||||||
| 2012-01-31 | -$322.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | -$484.05K derived: sum of 2 quarters · filed 2013-03-18 | -$434.95K 10-Q · filed 2013-03-18 | $70.12K derived: sum of 4 quarters · filed 2013-03-18 | $1.91M 10-Q · filed 2012-03-15 | ||||||||
| 2011-10-31 | -$161.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | -$112.74K 10-Q · filed 2012-12-14 | $392.34K derived: sum of 3 quarters · filed 2012-12-14 | $568.86K derived: sum of 4 quarters · filed 2012-12-14 | $2.23M 10-Q · filed 2011-12-15 | ||||||||
| 2011-07-31 | $49.09K 10-Q · filed 2012-09-19 | $554.17K derived: sum of 2 quarters · filed 2012-09-19 | $730.69K derived: sum of 3 quarters · filed 2012-09-19 | $939.24K derived: sum of 4 quarters · filed 2012-09-19 | $2.40M 10-Q · filed 2011-09-19 | ||||||||
| 2011-04-30 | $505.08K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $681.60K derived: sum of 2 quarters · filed 2012-07-25 | $890.15K derived: sum of 3 quarters · filed 2012-07-25 | $797.00K 10-K · filed 2012-07-25 | |||||||||
| 2011-01-31 | $176.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | $385.07K derived: sum of 2 quarters · filed 2012-03-15 | $291.92K 10-Q · filed 2012-03-15 | ||||||||||
| 2010-10-31 | $208.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $115.40K 10-Q · filed 2011-12-15 | |||||||||||
| 2010-07-31 | -$93.15K 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |